1-7 of 7
Cezary R Swider
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Dan T. Vogl, MD, MSCE, Edward A. Stadtmauer, MD, James Bradner, MD, Lisa Davis, PharmD, Thomas M. Paul, Emma C. Scott, MD, Charles W. Nichols, MD, David L. Porter, MD, Martin Carroll, MD, Janeen Kaplan, Gayle Mallon, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Ravi K. Amaravadi, MD
Journal: Blood
Blood (2011) 118 (21): 1869.
https://doi.org/10.1182/blood.V118.21.1869.1869
Published: 2011
Journal Articles

Effect of Obesity and Renal Insufficiency On Toxicity of High-Dose Melphalan for Multiple Myeloma.

Dan T. Vogl, Thomas M. Paul, Eric Stoopler, German Salazar, Lisa Davis, Shiv Kapoor, Babette Zemel, Mark Yudkoff, Gail Jackson, Lisa Basel-Brown, Kenneth Rockwell, Evgueni Daikhin, Cezary R. Swider, John Washington, Maria Raguza-Lopez, Thomas Tenhave, Edward A. Stadtmauer
Journal: Blood
Blood (2009) 114 (22): 1177.
https://doi.org/10.1182/blood.V114.22.1177.1177
Published: 2009
Journal Articles

Initial Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase I Clinical Trial of Systemic C-MYB Antisense Oligodeoxynucleotide in Subjects with Refractory Hematologic Malignancies

Noelle V Frey, Anna Kalota, Melissa Potuzak, Doris Shank, Cezary R Swider, Alison Loren, Edward Stadtmauer, Alexander Perl, Adam Cuker, Barbara Konkle, Suman Sood, Steven Goldstein, Margaret Kasner, David L Porter, Selina M Luger, Alan M Gewirtz
Journal: Blood
Blood (2008) 112 (11): 4033.
https://doi.org/10.1182/blood.V112.11.4033.4033
Published: 2008
Journal Articles

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Dan T. Vogl, Edward A. Stadtmauer, James E. Bradner, Lisa Davis, Martin Carroll, Charles W. Nichols, Doris Shank, Mary Carberry, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Craig B. Thompson, Ravi K. Amaravadi
Journal: Blood
Blood (2008) 112 (11): 3684.
https://doi.org/10.1182/blood.V112.11.3684.3684
Published: 2008
Journal Articles

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan, Cezary R. Swider, Candy Robinson, Shi Yang, Thelma Angeles, Stephen G. Emerson, Martin Carroll, Bruce Ruggeri, Pawel Dobrzanski
Journal: Blood
Blood (2008) 111 (12): 5663–5671.
https://doi.org/10.1182/blood-2007-04-083402
Published: 2008
Includes: Supplemental data
Journal Articles

Transcriptional Regulation of the Intra-S-Phase Regulator CDC7 in Human Myeloid Leukemic Cells: A New Downstream Target of the C-Myb Protooncogene.

Lindsay B. Thalheim, BA, Susan E. Shetzline, PhD, Cezary R. Swider, PhD, Alan M. Gewirtz, MD
Journal: Blood
Blood (2005) 106 (11): 1354.
https://doi.org/10.1182/blood.V106.11.1354.1354
Published: 2005
Journal Articles

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias

Susan E. Shetzline, Ravikumar Rallapalli, Kelley J. Dowd, Shaomin Zou, Yuji Nakata, Cezary R. Swider, Anna Kalota, John K. Choi, Alan M. Gewirtz
Journal: Blood
Blood (2004) 104 (6): 1833–1840.
https://doi.org/10.1182/blood-2003-10-3577
Published: 2004